Please use this identifier to cite or link to this item:
|Title:||Percutaneous device closure of abernethy malformation-A treatable cause of hepatopulmonary syndrome|
|Keywords:||Cardiovascular System & Cardiology|
|Publisher:||CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS|
|Abstract:||An eight-year-old girl was evaluated for unexplained cyanosis. A contrast echo was suggestive of pulmonary arteriovenous fistula. Further evaluation revealed Abernethy malformation (type 2) leading to hepatopulmonary syndrome. Percutaneous device closure of Abernethy malformation was done after anatomical and physiological evaluation of the portal circulation. Prior to closure, it is important to ensure adequate portal radicals into the liver and normal portal pressure after test balloon occlusion. Subcostal echocardiography can diagnose and guide device closure of Abernethy malformation, a treatable cause of hepatopulmonary syndrome. (c) 2013 Wiley Periodicals, Inc.|
|Appears in Collections:||Journal Articles|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.